Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05469386 · ClinicalTrials.gov registry record · Phase 4
Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom
A Phase 4 study of ADHD, sponsored by Florida International University.
- Active
- Registry status
- Phase 4
- Development phase
- 288
- Enrollment target
- 2
- Study locations
NCT05469386 is a Phase 4 study of ADHD that is active but no longer recruiting, run by Florida International University. The registered enrollment target is 288 participants, above the 186-participant average among 75 other ADHD trials with a reported enrollment target (55% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT05469386, a Phase 4 study of ADHD, is active but no longer recruiting, sponsored by Florida International University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 288 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is the first to systematically evaluate the efficacy of single and combined academic accommodation, behavioral treatment, and medication treatment in a large sample of children with ADHD. Using a scientifically rigorous, cross-over design the impact of these approaches on ecologically valid measures of outcome (on-task behavior, quiz scores, academic productivity) will be assessed to inform effective school intervention.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Methylphenidate Hydrochloride ER
- BEHAVIORAL Behavioral classroom
- BEHAVIORAL General Classroom
- BEHAVIORAL Academic Accommodations
Study Locations (2)
Florida
- FIU Center for Childern and Families - Miami
New York
- Center for Children and Families - Amherst
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2022-06-13 |
| Est. Completion | 2026-08-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05469386
The ClinicalTrials.gov registry entry for NCT05469386 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 186-participant average among 75 other ADHD trials with a reported enrollment target (55% higher). The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT05469386 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, New York.
Frequently Asked Questions
What is clinical trial NCT05469386 about?
NCT05469386 is a clinical study titled "Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom". This study is the first to systematically evaluate the efficacy of single and combined academic accommodation, behavioral treatment, and medication treatment in a large sample of children with ADHD. Using a scientifically rigorous, cross-over design the impact of these approaches on ecologically val...
What is the current status of trial NCT05469386?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 288 participants. The study started on 2022-06-13. Estimated completion is 2026-08-31.
What conditions does trial NCT05469386 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT05469386?
The interventions under investigation include: Placebo (DRUG), Methylphenidate Hydrochloride ER (DRUG), Behavioral classroom (BEHAVIORAL), General Classroom (BEHAVIORAL), Academic Accommodations (BEHAVIORAL).
Who is sponsoring clinical trial NCT05469386?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05469386 being conducted?
This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
-
Evaluating Treatment of ADHD in Children with Down Syndrome
RECRUITING · Phase 4
-
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
RECRUITING · Phase 4
-
AWARE: Management of ADHD in Autism Spectrum Disorder
RECRUITING · Phase 4
-
A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder
COMPLETED · Phase 4
-
Evaluation of an Intervention for Improving Community-based Pediatric Attention-Deficit Hyperactivity Disorder (ADHD) Care
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.